Abstract Number: 2679 • ACR/ARP Annual Meeting 2019
Tocilizumab in Giant Cell Arteritis: Route of Administration: Intravenous or Subcutaneous
Background/Purpose: Recently, based on the GiACTA trial results, weekly subcutaneous Tocilizumab (TCZ) has been approved for the treatment of Giant Cell Arteritis (GCA). It has…
Abstracts tagged "tocilizumab and safety"
Abstract Number: 2679 • ACR/ARP Annual Meeting 2019
Tocilizumab in Giant Cell Arteritis: Route of Administration: Intravenous or Subcutaneous
Background/Purpose: Recently, based on the GiACTA trial results, weekly subcutaneous Tocilizumab (TCZ) has been approved for the treatment of Giant Cell Arteritis (GCA). It has…
